浅岡忠史

アサオカタダフミ | Asaoka Tadafumi

所属機関・部署：
職名：大阪警察病院

研究分野 (1件)：消化器外科学

競争的資金等の研究課題 (3件)：

2019 - 2022 移植・再生医療に向けた肝・膵組織の三次元立体構築
2015 - 2019 細胞内シグナル伝達に着目した肝再生制御機構の解明と腫瘍細胞増殖制御への応用
2015 - 2018 形質転換と階層的複製能よりみた治療抵抗性肝癌に対する個別化治療についての研究

論文 (214件)：

Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Tadafumi Asaoka, Hironao Yasuoka, Daiki Marukawa, Yasuo Urata, Daisaku Yamada, Shogo Kobayashi, Hidetoshi Eguchi. Clinical impact of high-quality testing for peritoneal lavage cytology in pancreatic cancer. Scientific reports. 2024. 14. 1. 10199-10199
Shogo Kobayashi, Akira Tomokuni, Yutaka Takeda, Hiroshi Wada, Yoshiteru Katsura, Kazuhiko Hashimoto, Yoshito Tomimaru, Tadafumi Asaoka, Terumasa Yamada, Masanori Tsujie, et al. Exploratory prospective, randomized phase II study of neoadjuvant transcatheter arterial chemoembolization plus surgery versus surgery alone for large hepatocellular carcinoma (CSGO-HBP-005): Clinical Study Group of Osaka University, Hepato-Biliary-Pancreatic Group. Hepatology research : the official journal of the Japan Society of Hepatology. 2024
Tadafumi Asaoka, Kenta Furukawa, Manabu Mikamori, Satoshi Hyuga, Tomofumi Ohashi, Iwamoto Kazuya, Yujiro Nakahara, Atsushi Naito, Hidekazu Takahashi, Jeongho Moon, et al. Portal vein wedge resection and patch venoplasty with autologous vein grafts for hepatobiliary-pancreatic cancer. Surgical case reports. 2024. 10. 1. 27-27
Hidemi Nishi, Kunihito Gotoh, Yoshito Tomimaru, Shogo Kobayashi, Kazuki Sasaki, Yoshifumi Iwagami, Daisaku Yamada, Hirofumi Akita, Tadafumi Asaoka, Takehiro Noda, et al. Anti-tumor effect of avadomide in gemcitabine-resistant pancreatic ductal adenocarcinoma. Cancer chemotherapy and pharmacology. 2023. 92. 4. 303-314
Keisuke Oyama, Yoshifumi Iwagami, Shogo Kobayashi, Kazuki Sasaki, Daisaku Yamada, Yoshito Tomimaru, Takehiro Noda, Tadafumi Asaoka, Hidenori Takahashi, Masahiro Tanemura, et al. Removal of gemcitabine-induced senescent cancer cells by targeting glutaminase1 improves the therapeutic effect in pancreatic ductal adenocarcinoma. International journal of cancer. 2023

MISC (25件)：

Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Tadafumi Asaoka, Yasuo Urata, Kentaro Kishi, Daisaku Yamada, Shogo Kobayashi, Hidetoshi Eguchi. Development of modified telomerase-specific adenovirus-based identification for viable-peritoneal tumor cells in peritoneal lavage fluid in resectable pancreatic cancer. CANCER RESEARCH. 2022. 82. 12
Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Tadafumi Asaoka, Yasuo Urata, Kentaro Kishi, Daisaku Yamada, Shogo Kobayashi, Hidetoshi Eguchi. Development of modified telomerase-specific adenovirus-based identification for viable-peritoneal tumor cells in peritoneal lavage fluid in resectable pancreatic cancer. CANCER RESEARCH. 2022. 82. 12
Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Yusuke Matsuura, Kenichi Matsumoto, Tadafumi Asaoka, Yasuo Urata. Viable circulating tumor cells predict occult metastatic disease and prognosis, and aberrant expression of PD-L1 on viable CTC in pancreatic cancer. CANCER RESEARCH. 2021. 81. 13
宮崎葉月, 浅岡忠史, 花木武彦, 岩上佳史, 秋田裕史, 野田剛広, 後藤邦仁, 小林省吾, 川崎桂輔, 森井英一, et al. 経過観察中に浸潤癌の合併を認めた胆管内乳頭状腫瘍の1切除例. 胆道. 2020. 34. 4. 748-757
Masahiro Tanemura, Kenta Furukawa, Manabu Mikamori, Tadafumi Asaoka, Yasuo Urata, Kentaro Kishi. Clinical impact of new liquid biopsy using modified telomerase-specific adenovirus-based identification for viable-peritoneal tumor cells in peritoneal lavage fluid in resectable pancreatic cancer. CANCER RESEARCH. 2020. 80. 16

※　J-GLOBALの研究者情報は、researchmapの登録情報に基づき表示しています。登録・更新については、こちらをご覧ください。

前のページに戻る

浅岡 忠史

浅岡忠史